GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC is a wholly-owned subsidiary of Illumina, Inc. (NASDAQ:ILMN). For more information, please visit www.grail.com.
This role is part of a larger computational biology and machine learning group within the Bioinformatics & Data Science team at GRAIL whose work is at the heart of the company’s products: from diagnostic classifier algorithms for cancer screening to scientific software pipelines for rapid model development. You will work with diverse teams including software, clinical, operations, research, product development, and external collaborators. Your work will result in exciting discoveries in cancer biology, impactful publications, and potential future products. You will report to Amoolya Singh, Chief Scientific Officer and SVP data science.
-
Lead and grow a group of bioinformaticians and computational biologists working to apply GRAIL’s cancer diagnostics capabilities to the drug discovery process
-
Members of your team may be matrixed to a variety of external collaboration projects with biopharma partners
-
Partner with GRAIL’s pharma business development team on diligence, scoping, resourcing, and execution of collaborative oncology projects at the interface of drug discovery research and translation
-
Partner with peers leading ML/computational biology research to iteratively develop novel biological insights and computational models for pharma applications
-
Lead the efforts to showcase our work to potential collaborators and customers
-
MD, or MS or PhD in any quantitative science
-
Background in oncology and 5+ years experience in the biopharma sector, which includes expertise in any of the following activities: target discovery or validation, preclinical studies, clinical trials, or post-marketing and real-world evidence monitoring
-
Demonstrated experience in managing complex biomedical projects with internal and external dependencies
-
Mastery of working collaboratively under tight deadlines and balancing the needs of multiple key stakeholders
-
Results-oriented: superb follow-through, drive, and creative problem-solving
-
Clear, positive, and proactive communicator in verbal and written communications
-
Outstanding manager with unconscious competence in relevant best practices (e.g. active listening, delegation, feedback, resolving conflict, coaching, and career development)
-
Experience with companion diagnostics, biomarkers, or clinical genomics
-
Disciplinary expertise in immunology or computational biology
The estimated, full-time, annual base pay scale for this position is $281,000 - $403,000. Actual base pay will consider skills, experience, and location.
Based on the role, colleagues may be eligible to participate in an annual bonus plan tied to company and individual performance, or an incentive plan. We also offer a long-term incentive plan to align company and colleague success over time.
In addition, GRAIL offers a progressive benefit package, including flexible time-off, a 401k with a company match, and alongside our medical, dental, vision plans, carefully selected mindfulness offerings.
GRAIL is an Equal Employment Office and Affirmative Action Employer and does not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other legally protected status. We will reasonably accommodate all individuals with disabilities so that they can participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
Following extensive monitoring, consideration of business implications, and advice from internal and external experts, GRAIL US has made the decision to require that all U.S. employees be “Fully Vaccinated” with the COVID-19 vaccine. “Fully Vaccinated” is defined as two weeks after both doses of a two-dose vaccine (e.g. Pfizer or Moderna) or two weeks since a single-dose vaccine (e.g. Johnson & Johnson) has been administered. Absent a qualifying exemption, all GRAIL US employees are to comply with this requirement, including providing documentation of such vaccination status, as a condition of employment. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation for consideration by GRAIL.